Updated patient site for Bristol-Myers Squibb

Bristol-Myers Squibb (BMS) is a global pharmaceutical company. We have worked together with BMS for over 10 years and have, among other things, developed a LIF-approved patient site for the drug Eliquis, a drug in the field of cardiovascular disease.

Today’s patients want modern digital aids to get clear information and good support during treatment. A patient site meets patients’ needs and contributes to increased patient safety. We launched the patient site Eliquispatient together with BMS several years ago and now it was time for a major further development of the site.

The updated site has, among other things, been given full width for a more modern feel. There are also a number of new digital aids – such as a glossary for easier understanding of words in treatment, a pulse and electrical conversion calendar that the patient can fill out online and bring to their doctor, as well as new flipchart patient brochures.

We have extensive experience of developing patient sites in accordance with LIF’s regulations. On a patient site, you can write the name of the product and substance, use the product logo and brand colors. It is also possible to describe indications, reach out with patient support programs and use other methods to convey information such as film, illustrations and graphic objects.

Feel free to visit that site: https://eliquispatient.se